Related Experiment Videos
Modification of Epstein-Barr virus replication by tunicamycin
Journal of Virology
|January 1, 1986
Summary
Tunicamycin, an inhibitor of N-linked glycosylation, significantly reduced Epstein-Barr virus production. This suggests viral glycoproteins are crucial for virus penetration and infection, not just attachment.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Epstein-Barr virus (EBV) is a human herpesvirus associated with various cancers and autoimmune diseases.
- N-linked glycosylation is a critical post-translational modification for viral glycoprotein function and virus assembly.
- The precise role of N-linked glycosylated viral proteins in EBV replication and infectivity remains incompletely understood.
Purpose of the Study:
- To investigate the impact of inhibiting N-linked glycosylation using tunicamycin on Epstein-Barr virus replication.
- To determine the specific stages of the viral life cycle affected by tunicamycin treatment.
- To elucidate the role of viral glycoproteins in EBV attachment, penetration, and B cell activation.
Main Methods:
- Treatment of EBV-producing cells (P3HR1-Cl13 and MCUV5) with varying concentrations of tunicamycin.
- Quantification of viral yield and intracellular viral accumulation.
- Assessment of viral DNA synthesis.
- Analysis of viral glycoprotein expression and cell surface insertion.
- Evaluation of virus binding to B cells and induction of immunoglobulin secretion.
Main Results:
- Tunicamycin significantly reduced EBV yield in a dose-dependent manner.
- Intracellular viral accumulation was observed at lower tunicamycin concentrations, while viral DNA synthesis was inhibited at higher concentrations.
- N-linked sugar-deficient viral glycoproteins were inserted into the cell membrane.
- The reduced amount of virus produced retained the ability to bind specifically to B cell receptors.
- The capacity of the virus to induce immunoglobulin secretion in human lymphocytes was impaired.
Conclusions:
- N-linked glycosylation is essential for efficient Epstein-Barr virus replication and high viral yield.
- Viral glycoproteins play a critical role not only in EBV attachment but also in the penetration of target cells.
- Inhibition of glycosylation affects multiple stages of the EBV life cycle, including DNA synthesis and infectivity.